MID-VOLUME · HOSP-HEAVY
ceftriaxone Side Effects
ceftriaxone (also sold as Rocephin) sits MID-VOLUME #183 of 524 by FAERS report count. Lead signal: HOSP-HEAVY - 54.3% mention hospitalization (17,015 reports). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 31,340
- FAERS reports
FDA Adverse Event Reporting System extract for ceftriaxone. Stamp set CASELOAD · DEATH-HEAVY · HOSP-HEAVY. How figures are compiled.
ceftriaxone: 54.3% mention hospitalization (17,015 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #183 of 524 by FAERS report count.
Mid-book FAERS page for ceftriaxone (Rocephin) (31,340 reports). Signature HOSP-HEAVY. Dominant age band on file: 45-64. Educational reference only.
Counts from the openFDA FAERS extract (2003–2025). Stamps CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
PYREXIA leads 1,677 of 31,340 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (7,538 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (5,390 reports, 17.2%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| MULTIPLE ORGAN DYSFUNCTION SYNDROME | 518 |
| DEATH | 494 |
| SEPSIS | 442 |
| CONDITION AGGRAVATED | 431 |
| RESPIRATORY FAILURE | 396 |
| SEPTIC SHOCK | 386 |
| CARDIAC ARREST | 346 |
| PNEUMONIA | 325 |
| GENERAL PHYSICAL HEALTH DETERIORATION | 318 |
| ACUTE KIDNEY INJURY | 303 |
| PYREXIA | 298 |
| DYSPNOEA | 265 |
| NAUSEA | 264 |
| VOMITING | 258 |
| HYPONATRAEMIA | 257 |
| RENAL FAILURE | 244 |
| ABDOMINAL PAIN | 238 |
| HYPOTENSION | 229 |
Reactions in Hospitalization Reports
Hospitalization is HEAVY (17,015, 54.3% of the book). Top reactions in those rows:
| Reaction | Reports |
|---|---|
| PYREXIA | 1,239 |
| ACUTE KIDNEY INJURY | 1,014 |
| PNEUMONIA | 807 |
| CONDITION AGGRAVATED | 779 |
| DYSPNOEA | 680 |
| VOMITING | 640 |
| DIARRHOEA | 609 |
| DRUG INTERACTION | 587 |
| NAUSEA | 583 |
| SEPSIS | 562 |
| HYPOTENSION | 550 |
| DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS | 542 |
| ANAEMIA | 515 |
| THROMBOCYTOPENIA | 474 |
| ABDOMINAL PAIN | 473 |
| RASH | 473 |
| RESPIRATORY FAILURE | 473 |
| SEPTIC SHOCK | 437 |
How to read ceftriaxone FAERS figures (CASELOAD · DEATH-HEAVY · HOSP-HEAVY)
FAERS holds 31,340 voluntary reports linked to ceftriaxone (Rocephin), 2003-2025. Death is listed on 5,390 (17.2%). Hospitalization appears on 17,015 (54.3%). Top co-reported indication: Product Used For Unknown Indication.
Mid-volume extract - treat DEATH-HEAVY · HOSP-HEAVY as signal-detection rates next to 54.3% mention hospitalization (17,015 reports).
Read with ceftriaxone
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-HEAVY stamps.
ABS(total_reports) peer at 31,347 FAERS cases (Δ 7 heavier vs ceftriaxone); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 31,164 FAERS cases (Δ 176 lighter vs ceftriaxone); DEATH-MARKED · HOSP-LIGHT · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 31,122 FAERS cases (Δ 218 lighter vs ceftriaxone); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(total_reports) peer at 31,083 FAERS cases (Δ 257 lighter vs ceftriaxone); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 44.9 pp vs ceftriaxone's DEATH-HEAVY): CASELOAD · HOSP-MID.
ceftriaxone stamps DEATH-HEAVY · HOSP-HEAVY; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload CASELOAD and the label guide.